BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12231413)

  • 1. Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats.
    Mo A; Yao W; Li C; Tian X; Su M; Ling Y; Zhang Q; Setterberg RB; Jee WS
    Bone; 2002 Sep; 31(3):402-6. PubMed ID: 12231413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
    Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
    Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats.
    Chen JL; Yao W; Frost HM; Li CY; Setterberg RB; Jee WS
    Bone; 2001 Aug; 29(2):126-33. PubMed ID: 11502473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
    Ke HZ; Li M; Jee WS
    Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ; Shen VW; Qi H; Crawford DT; Wu DD; Liang XG; Chidsey-Frink KL; Pirie CM; Simmons HA; Thompson DD
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
    Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making rats rise to erect bipedal stance for feeding partially prevented orchidectomy-induced bone loss and added bone to intact rats.
    Yao W; Jee WS; Chen J; Liu H; Tam CS; Cui L; Zhou H; Setterberg RB; Frost HM
    J Bone Miner Res; 2000 Jun; 15(6):1158-68. PubMed ID: 10841185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; SamnegÄrd E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H; Ke HZ; Jee WS; Sakou T
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erect bipedal stance exercise partially prevents orchidectomy-induced bone loss in the lumbar vertebrae of rats.
    Yao W; Jee WS; Chen J; Tam CS; Setterberg RB; Frost HM
    Bone; 2000 Nov; 27(5):667-75. PubMed ID: 11062354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
    Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
    Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
    Erben RG; Bromm S; Stangassinger M
    Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
    Jee WS; Mori S; Li XJ; Chan S
    Bone; 1990; 11(4):253-66. PubMed ID: 2242291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.